Table of Content

1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value by Application: (2024-2034)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2018-2034
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2018-2034
1.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs, Product Type & Application
2.7 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue
2.7.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region: 2018-2034
3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region: 2018-2024
3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region: 2024-2034
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2018-2034
3.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2018-2024
3.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2024-2034
3.4 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.4.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2034)
3.4.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.5.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2034)
3.5.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.7.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2034)
3.7.3 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2018-2034)
4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2018-2024)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2024-2034)
4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2018-2034)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2018-2034)
4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2018-2024)
4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2024-2034)
4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2018-2034)
5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2018-2024)
5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2024-2034)
5.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2018-2034)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2018-2034)
5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2018-2024)
5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2024-2034)
5.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Tesaro, Inc.
6.3.1 Tesaro, Inc. Corporation Information
6.3.2 Tesaro, Inc. Description and Business Overview
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.3.5 Tesaro, Inc. Recent Developments/Updates
6.4 Helsinn Group
6.4.1 Helsinn Group Corporation Information
6.4.2 Helsinn Group Description and Business Overview
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.4.5 Helsinn Group Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 Heron Therapeutics, Inc.
6.6.1 Heron Therapeutics, Inc. Corporation Information
6.6.2 Heron Therapeutics, Inc. Description and Business Overview
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.6.5 Heron Therapeutics, Inc. Recent Developments/Updates
6.7 Dr. Reddy's Laboratories Ltd.
6.6.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.6.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.8 Acacia Pharma
6.8.1 Acacia Pharma Corporation Information
6.8.2 Acacia Pharma Description and Business Overview
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.8.5 Acacia Pharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Otsuka Holdings Co., Ltd. Corporation Information
6.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.10.5 Otsuka Holdings Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Analysis
7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chemotherapy-Induced Nausea and Vomiting Drugs Production Mode & Process
7.4 Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Marketing
7.4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channels
7.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
7.5 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
8 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
8.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Chemotherapy-Induced Nausea and Vomiting Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Merck & Co., Inc. Corporation Information
Table 71. Merck & Co., Inc. Description and Business Overview
Table 72. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 74. Merck & Co., Inc. Recent Developments/Updates
Table 75. GlaxoSmithKline plc Corporation Information
Table 76. GlaxoSmithKline plc Description and Business Overview
Table 77. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 79. GlaxoSmithKline plc Recent Developments/Updates
Table 80. Tesaro, Inc. Corporation Information
Table 81. Tesaro, Inc. Description and Business Overview
Table 82. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 84. Tesaro, Inc. Recent Developments/Updates
Table 85. Helsinn Group Corporation Information
Table 86. Helsinn Group Description and Business Overview
Table 87. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 89. Helsinn Group Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd. Corporation Information
Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 94. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 95. Heron Therapeutics, Inc. Corporation Information
Table 96. Heron Therapeutics, Inc. Description and Business Overview
Table 97. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 99. Heron Therapeutics, Inc. Recent Developments/Updates
Table 100. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 101. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 102. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 104. Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
Table 105. Acacia Pharma Corporation Information
Table 106. Acacia Pharma Description and Business Overview
Table 107. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 109. Acacia Pharma Recent Developments/Updates
Table 110. Sun Pharmaceutical Industry Ltd. Corporation Information
Table 111. Sun Pharmaceutical Industry Ltd. Description and Business Overview
Table 112. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 114. Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
Table 115. Otsuka Holdings Co., Ltd. Corporation Information
Table 116. Otsuka Holdings Co., Ltd. Description and Business Overview
Table 117. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 119. Otsuka Holdings Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
Table 123. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
Table 124. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Table 125. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
Table 126. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
Table 127. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2022 & 2034
Figure 4. Existing Drugs Product Picture
Figure 5. Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure 6. Aloxi (Palonosetron) Product Picture
Figure 7. Emend (Aprepitant) Product Picture
Figure 8. Kytril Generic (Granisetron) Product Picture
Figure 9. Zofran Generic (Ondansetron) Product Picture
Figure 10. Pipeline Drugs Product Picture
Figure 11. SUSTOL (Granisetron Injection extended release) Product Picture
Figure 12. Rolapitant Product Picture
Figure 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2022 & 2034
Figure 15. Serotonin Receptor Antagonists
Figure 16. NK1 Receptor Antagonists
Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2018-2034) & (US$ Million)
Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (2018-2034) & (K Units)
Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) & (2018-2034)
Figure 21. Chemotherapy-Induced Nausea and Vomiting Drugs Report Years Considered
Figure 22. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturers in 2022
Figure 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players: Market Share by Revenue in 2022
Figure 25. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 27. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2018-2034)
Figure 28. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2018-2034)
Figure 29. U.S. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2018-2034)
Figure 32. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2018-2034)
Figure 33. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2018-2034)
Figure 39. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2018-2034)
Figure 40. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Taiwan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Indonesia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Thailand Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Malaysia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Philippines Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2018-2034)
Figure 51. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2018-2034)
Figure 52. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2018-2034)
Figure 56. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2018-2034)
Figure 57. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. U.A.E Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. Global Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2018-2034)
Figure 61. Global Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2018-2034)
Figure 62. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2018-2034)
Figure 63. Global Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2018-2034)
Figure 64. Global Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2018-2034)
Figure 65. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2018-2034)
Figure 66. Chemotherapy-Induced Nausea and Vomiting Drugs Value Chain
Figure 67. Chemotherapy-Induced Nausea and Vomiting Drugs Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed